Merck Manual

Please confirm that you are a health care professional

honeypot link

Cutaneous Vasculitis

(Cutaneous Leukocytoclastic Vasculitis; Cutaneous Small Vessel Vasculitis; Leukoclastic Vasculitis; Cutaneous Leukocytoclastic Angiitis; Cutaneous Necrotizing Venulitis; Hypersensitivity Vasculitis)


Alexandra Villa-Forte

, MD, MPH, Cleveland Clinic

Reviewed/Revised Jun 2022 | Modified Sep 2022
Topic Resources

Cutaneous vasculitis refers to vasculitis affecting small- or medium-sized vessels in the skin and subcutaneous tissue but not the internal organs. Cutaneous vasculitis may be limited to the skin, or may be a component of a systemic primary or secondary vasculitic disorder. Purpura, petechiae, or ulcers may develop. Diagnosis requires biopsy. Treatment depends on etiology and extent of disease.

Vasculitis can affect the small- or medium-sized vessels of the skin. Vasculitis affecting the small vessels of the skin (eg, arterioles, capillaries, postcapillary venules) tends to cause lesions such as purpura, petechiae, and possibly shallow ulcers. Livedo reticularis, nodules, and deep ulcers are usually caused by vasculitis of deeper, medium or large vessels. Any primary or secondary vasculitis can affect the skin, including that due to serum sickness, infections (eg, hepatitis C), cancers, rheumatologic or other autoimmune disorders, and hypersensitivity to drugs.

Terms used to describe cutaneous vasculitis can overlap and have been used inconsistently in the literature:

  • Cutaneous vasculitis: This term describes vasculitis that affects the skin but not the internal organs.

  • Cutaneous small-vessel vasculitis (CSVV): This term describes vasculitis that affects the small vessels of the skin but not the internal organs. CSVV sometimes refers to small-vessel vasculitis of unknown cause (also called idiopathic cutaneous small-vessel vasculitis).

  • Leukocytoclastic vasculitis: This term describes a common type of CSVV, so-called because inflammation consists initially of neutrophils, which after degranulation result in deposition of nuclear debris (leukocytoclasis) in the vessel wall.

  • Hypersensitivity vasculitis: This term previously used to mean CSVV but is now usually not used because the cause of CSVV is usually not hypersensitivity. However, hypersensitivity vasculitis is sometimes used to refer to CSVV caused by a known drug or infection.

Symptoms and Signs of Cutaneous Vasculitis

Patients may present with skin symptoms such as lesions, including palpable purpura, petechiae, urticaria, ulcers, livedo reticularis, and nodules. If skin involvement is secondary to a systemic vasculitis, symptoms may also include fever, arthralgias, other organ involvement, or a combination.

Diagnosis of Cutaneous Vasculitis

  • Exclusion of clinically evident causes of systemic vasculitis

  • Routine tests (eg, complete blood count, erythrocyte sedimentation rate, urinalysis, serum creatinine, chest x-ray)

  • Biopsy

  • Tests to identify the type and etiology of vasculitis (eg, cryoglobulins, antineutrophil cytoplasmic antibodies, hepatitis B and C antibodies, C3 and C4 complement levels, rheumatoid factor, blood cultures, protein electrophoresis)

A diagnosis of vasculitis limited to the skin requires a complete history and physical examination. Evaluation is focused at identifying causes, such as new drugs or infections, and excluding manifestations of inflammation or vasculitis in other organs, such as

  • Lungs: Shortness of breath, cough, hemoptysis, and signs of consolidation

  • Kidneys: New-onset hypertension or edema

  • Nerves: New-onset asymmetric weakness or paresthesias

  • Intestine: New-onset abdominal pain, diarrhea, and bloody stools

Urinalysis should exclude blood, protein, and red blood cell casts. A chest x-ray is needed to check for infiltrates (suggesting alveolar hemorrhage). Complete blood count and other blood tests are needed to check for anemia, to determine platelet count and serum creatinine level, and to check for elevated levels of acute-phase reactants (eg, erythrocyte sedimentation rate, C-reactive protein). Leukopenia and thrombocytopenia are not typical of cutaneous vasculitis and prompt consideration of an alternate diagnosis.

Skin biopsy should be done, optimally within 24 to 48 hours after vasculitic lesions appear. Diagnostic yield depends on the depth and timing of the biopsy. Generally, deep punch biopsy or excision biopsy into the subcutis is preferred; these biopsies can sample small- and medium-sized vessels. Shave biopsy is usually inadequate.

If histologic examination detects the following, cutaneous vasculitis is confirmed:

  • Infiltration of the vessel wall by inflammatory cells, resulting in disruption and destruction of the vessel wall

  • Intramural and intraluminal fibrin deposition (fibrinoid necrosis)

  • Extravasation of red blood cells

  • Nuclear debris (leukocytoclasis)

Direct immunofluorescence staining is needed to check for IgA, IgM, and IgG and complement deposition in and around the vessel wall, which suggests an immune complex–mediated process, a myeloid or lymphoproliferative disorder, or other neoplastic disorder, especially in adults. IgA deposition has been associated with renal, joint, and gastrointestinal manifestations, but IgG and IgM have not. Direct immunofluorescence staining may be positive for IgM or IgG in cryoglobulinemic vasculitis or rheumatoid arthritis and for IgA in immunoglobulin A–associated vasculitis.

Tests done to identify the cause of vasculitis include cryoglobulins, antineutrophil cytoplasmic antibodies (ANCA), hepatitis B and C antibodies, C3 and C4 levels, rheumatoid factor, blood cultures, and serum and urine protein electrophoresis. Other tests are done as needed to identify clinically suspected causes of vasculitis.

Treatment of Cutaneous Vasculitis

  • Treatment of the cause when possible

  • Initial drug options include colchicine, hydroxychloroquine, dapsone, or a short course of low-dose corticosteroids as needed

Treatment of cutaneous vasculitis is first directed at any identified cause when possible (eg, hepatitis C causing cryoglobulinemia). If no cause is identified and vasculitis is limited to the skin, treatment is minimal and conservative. Colchicine, hydroxychloroquine, dapsone, or a short course of low-dose corticosteroids can be tried.

Sometimes, stronger immunosuppressants (eg, azathioprine, methotrexate) are used, particularly if lesions ulcerate or if corticosteroids must be taken indefinitely to control symptoms.

Key Points

  • Cutaneous vasculitis affects small- and medium-sized vessels and can be primary or secondary.

  • Manifestations can include palpable purpura, petechiae, urticaria, ulcers, livedo reticularis, and nodules.

  • Exclude other causes of vasculitis.

  • Do routine laboratory tests and biopsy.

  • Treat the cause when possible.

Drugs Mentioned In This Article

Drug Name Select Trade
Plaquenil, Quineprox
Azasan, Imuran
Otrexup, Rasuvo, RediTrex, Rheumatrex, Trexall, Xatmep
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz!